Ameriprise
AZN icon

Ameriprise’s AstraZeneca AZN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$352M Buy
5,046,992
+104,625
+2% +$7.29M 0.09% 237
2025
Q1
$364M Buy
4,942,367
+261,064
+6% +$19.2M 0.1% 217
2024
Q4
$306M Buy
4,681,303
+390,407
+9% +$25.6M 0.08% 252
2024
Q3
$334M Sell
4,290,896
-595,207
-12% -$46.3M 0.09% 240
2024
Q2
$382M Buy
4,886,103
+35,312
+0.7% +$2.76M 0.1% 207
2024
Q1
$328M Buy
4,850,791
+406,187
+9% +$27.5M 0.09% 233
2023
Q4
$299M Buy
4,444,604
+201,896
+5% +$13.6M 0.09% 235
2023
Q3
$287M Buy
4,242,708
+201,104
+5% +$13.6M 0.09% 217
2023
Q2
$289M Buy
4,041,604
+831,470
+26% +$59.5M 0.09% 230
2023
Q1
$223M Sell
3,210,134
-24,733
-0.8% -$1.72M 0.07% 278
2022
Q4
$219M Sell
3,234,867
-282,222
-8% -$19.1M 0.08% 270
2022
Q3
$193M Sell
3,517,089
-168,418
-5% -$9.24M 0.07% 285
2022
Q2
$243M Sell
3,685,507
-275,666
-7% -$18.2M 0.08% 250
2022
Q1
$263M Buy
3,961,173
+214,937
+6% +$14.3M 0.08% 267
2021
Q4
$218M Buy
3,746,236
+1,011,472
+37% +$58.9M 0.06% 331
2021
Q3
$164M Buy
2,734,764
+2,508,987
+1,111% +$151M 0.05% 378
2021
Q2
$13.5M Sell
225,777
-115,313
-34% -$6.91M ﹤0.01% 1669
2021
Q1
$17M Sell
341,090
-20,886
-6% -$1.04M 0.01% 1455
2020
Q4
$18.1M Buy
361,976
+83,294
+30% +$4.16M 0.01% 1295
2020
Q3
$15.3M Sell
278,682
-69,061
-20% -$3.78M 0.01% 1250
2020
Q2
$18.4M Sell
347,743
-22,490
-6% -$1.19M 0.01% 1103
2020
Q1
$16.5M Buy
370,233
+4,380
+1% +$196K 0.01% 1056
2019
Q4
$18.2M Buy
365,853
+36,805
+11% +$1.84M 0.01% 1263
2019
Q3
$14.7M Sell
329,048
-1,377
-0.4% -$61.4K 0.01% 1384
2019
Q2
$13.6M Sell
330,425
-110,142
-25% -$4.55M 0.01% 1478
2019
Q1
$17.8M Sell
440,567
-233,718
-35% -$9.45M 0.01% 1228
2018
Q4
$25.6M Buy
674,285
+23,412
+4% +$889K 0.01% 920
2018
Q3
$25.8M Sell
650,873
-1,735,824
-73% -$68.7M 0.01% 1111
2018
Q2
$83.9M Sell
2,386,697
-607,129
-20% -$21.3M 0.04% 460
2018
Q1
$105M Sell
2,993,826
-168,227
-5% -$5.9M 0.05% 369
2017
Q4
$110M Buy
3,162,053
+135,272
+4% +$4.71M 0.05% 353
2017
Q3
$103M Buy
3,026,781
+199,519
+7% +$6.77M 0.05% 361
2017
Q2
$96.8M Buy
2,827,262
+157,293
+6% +$5.38M 0.05% 360
2017
Q1
$83.9M Buy
2,669,969
+513,528
+24% +$16.1M 0.04% 390
2016
Q4
$58.5M Buy
2,156,441
+381,243
+21% +$10.3M 0.03% 481
2016
Q3
$58.4M Buy
1,775,198
+509,236
+40% +$16.8M 0.03% 452
2016
Q2
$38.2M Buy
1,265,962
+338,514
+36% +$10.2M 0.02% 591
2016
Q1
$25.5M Buy
927,448
+209,301
+29% +$5.75M 0.02% 786
2015
Q4
$24.4M Buy
718,147
+9,521
+1% +$324K 0.01% 822
2015
Q3
$22.7M Buy
708,626
+140,374
+25% +$4.5M 0.01% 854
2015
Q2
$36.2M Buy
568,252
+372,148
+190% +$23.7M 0.02% 658
2015
Q1
$13.4M Sell
196,104
-738,512
-79% -$50.5M 0.01% 1315
2014
Q4
$65.8M Buy
934,616
+741,920
+385% +$52.2M 0.04% 434
2014
Q3
$13.8M Buy
192,696
+19,382
+11% +$1.38M 0.01% 1207
2014
Q2
$12.9M Sell
173,314
-675,500
-80% -$50.2M 0.01% 1337
2014
Q1
$55.1M Sell
848,814
-136,016
-14% -$8.83M 0.03% 506
2013
Q4
$58.5M Buy
984,830
+43,403
+5% +$2.58M 0.04% 478
2013
Q3
$48.9M Sell
941,427
-972,093
-51% -$50.5M 0.03% 529
2013
Q2
$90.5M Buy
+1,913,520
New +$90.5M 0.06% 345